216
Participants
Start Date
September 30, 2004
Primary Completion Date
February 28, 2007
Study Completion Date
April 30, 2016
Gefitinib
Placebo
Research Site, Bedford Park
Research Site, Chermside
Research Site, Concord
Research Site, Melbourne
Research Site, Newcastle
Research Site, Prahran
Research Site, Randwick
Research Site, Calgary
Research Site, Edmonton
Research Site, Kelowna
Research Site, Surrey
Research Site, Winnipeg
Research Site, Moncton
Research Site, Halifax
Research Site, Barrie
Research Site, Hamilton
Research Site, Kingston
Research Site, London
Research Site, Mississauga
Research Site, Newmarket
Research Site, Oshawa
Research Site, Ottawa
Research Site, Sault Ste. Marie
Research Site, Thunder Bay
Research Site, Toronto
Research Site, Nová Ves pod Pleší
Research Site, 's-Hertogenbosch
Research Site, Amsterdam
Research Site, Eindhoven
Research Site, The Hague
Research Site, Zutphen
Research Site, Abergavenny
Research Site, Birmingham
Research Site, Cardiff
Research Site, Leeds
Research Site, Wolverhampton
Lead Sponsor
AstraZeneca
INDUSTRY